BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18211969)

  • 1. Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy.
    Bech P; Winstanley V; Murphy KG; Sam AH; Meeran K; Ghatei MA; Bloom SR
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1246-53. PubMed ID: 18211969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
    Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia.
    Bech PR; Martin NM; Ramachandran R; Bloom SR
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):8-21. PubMed ID: 23939195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.
    Bech PR; Ramachandran R; Dhillo WS; Martin NM; Bloom SR
    Clin Chem; 2012 May; 58(5):941-3. PubMed ID: 22361937
    [No Abstract]   [Full Text] [Related]  

  • 5. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
    Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of chromogranin B can serve as a complement to chromogranin A.
    Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
    Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues.
    Murphy KG; Abbott CR; Mahmoudi M; Hunter R; Gardiner JV; Rossi M; Stanley SA; Ghatei MA; Kuhar MJ; Bloom SR
    J Endocrinol; 2000 Sep; 166(3):659-68. PubMed ID: 10974659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
    Conlon JM
    Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors.
    Yasuda D; Iguchi H; Funakoshi A; Wakasugi H; Sekiya K; Misawa T; Tateishi K; Bloom SR; Nawata H
    Horm Metab Res; 1993 Nov; 25(11):593-5. PubMed ID: 8288164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
    Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
    Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit.
    Larsen PJ; Seier V; Fink-Jensen A; Holst JJ; Warberg J; Vrang N
    J Neuroendocrinol; 2003 Mar; 15(3):219-26. PubMed ID: 12588509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short- and long-term physical activities on circulating granin protein levels.
    Røsjø H; Opstad PK; Hoff JE; Godang K; Christensen G; Stridsberg M; Omland T
    Regul Pept; 2013 Aug; 185():14-9. PubMed ID: 23816467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas.
    Børglum T; Rehfeld JF; Drivsholm LB; Hilsted L
    Clin Chem; 2007 Mar; 53(3):438-46. PubMed ID: 17259235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors.
    Landerholm K; Falkmer SE; Järhult J; Sundler F; Wierup N
    Neuroendocrinology; 2011; 94(3):228-36. PubMed ID: 21832817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine- and amphetamine-regulated transcript-immunoreactivity in the rat sympatho-adrenal axis.
    Dun NJ; Dun SL; Kwok EH; Yang J; Chang J
    Neurosci Lett; 2000 Apr; 283(2):97-100. PubMed ID: 10739884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Janson ET
    Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies.
    Syversen U; Opsjøn SL; Stridsberg M; Sandvik AK; Dimaline R; Tingulstad S; Arntzen KJ; Brenna E; Waldum HL
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4470-5. PubMed ID: 8954061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
    Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
    J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.